Inventor
KEITH JENDZA
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,129,246Hydroquinazoline derivatives for the treatment of a disease or disorder202412,122,7612-azaspiro[3.4]octane derivatives as M4 agonists202411,820,7782-azaspiro[3.4]octane derivatives as M4 agonists202311,548,8652-azaspiro[3.4]octane derivatives as M4 agonists202311,485,7422-azaspiro[3.4]octane derivatives as M4 agonists2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to NOVARTIS AG (5)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 5 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2024 |